Monitoring of intracellular levels of 5′-monophosphate-AZT using an enzyme immunoassay

被引:13
作者
Goujon, L
Brossette, T
Dereudre-Bosquet, N
Creminon, C
Clayette, P
Dormont, D
Mioskowski, C
Lebeau, L
Grassi, J
机构
[1] CEA Saclay, Serv Pharmacol & Immunol, Dept Rech Med, F-91191 Gif Sur Yvette, France
[2] Univ Louis Pasteur Strasbourg 1, Fac Pharm, CNRS URA 1386, Lab Synth Bioorgan, F-67401 Illkirch Graffenstaden, France
[3] CEA Fontenay Aux Roses, Det Rech Med, Serv Neurovirol, CRSSA, F-92265 Fontenay Aux Roses, France
关键词
intracellular levels; 5 '-monophosphate-AZT; enzyme immunoassay;
D O I
10.1016/S0022-1759(98)00101-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We have developed a competitive enzyme immunoassay suitable for routine monitoring of intracellular levels of 5'-monophosphate-AZT (AZT-MP). This assay is performed in 96-well microtiter plates coated with anti-rabbit immunoglobulin antibodies and is based on the use of rabbit polyclonal antibodies raised against an AZT-MP analog and of an AZT-MP/acetylcholinesterase conjugate as tracer. It is very sensitive, with a detection Limit close to 0.1 ng/ml (0.2 pmol/ml), and precise (CV < 20% from 20 to 0.3 ng/ml). Very low cross-reactivities were observed with AZT and the corresponding di- and triphosphate derivatives as well as with other related nucleotides and nucleosides. The validity of the assay was demonstrated by measuring intracellular concentrations of AZT-MP in peripheral blood mononuclear cells (PBMCs) and in monocyte-derived macrophages (MDMs) cultured in the presence of various concentrations of AZT (from 0.01 mu M to 10 mu M). We observed very high levels of AZT-MP in stimulated (PHA + IL2) PBMCs (> 100 pmol/10(6) cells) while, as expected, much lower concentrations were measured in resting PBMCs or MDMs (0.1 to 2 pmol/10(6) cells). The assay constitutes a very convenient tool permitting easy, precise studies of the first step of the intracellular metabolism of AZT leading to the formation of AZT-TP in cultured cells. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:19 / 30
页数:12
相关论文
共 43 条
[1]   Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase [J].
Antonelli, G ;
Turriziani, O ;
Verri, A ;
Narciso, P ;
Ferri, F ;
DOffizi, G ;
Dianzani, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (03) :223-228
[2]  
ARTS, 1997, ANTIRETROVIRAL THERA
[3]   THE INVITRO AND INVIVO ANTI-RETROVIRUS ACTIVITY, AND INTRACELLULAR METABOLISM OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE AND 2',3'-DIDEOXYCYTIDINE ARE HIGHLY DEPENDENT ON THE CELL SPECIES [J].
BALZARINI, J ;
PAUWELS, R ;
BABA, M ;
HERDEWIJN, P ;
DECLERCQ, E ;
BRODER, S ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :897-903
[4]  
BALZARINI J, 1989, J BIOL CHEM, V264, P6127
[5]   ZIDOVUDINE PHOSPHORYLATION IN HIV-INFECTED PATIENTS AND SERONEGATIVE VOLUNTEERS [J].
BARRY, M ;
WILD, M ;
VEAL, G ;
BACK, D ;
BRECKENRIDGE, A ;
FOX, R ;
BEECHING, N ;
NYE, F ;
CAREY, P ;
TIMMINS, D .
AIDS, 1994, 8 (08) :F1-F5
[6]   INHIBITION OF MAMMALIAN DNA POLYMERASE-ASSOCIATED 3' TO 5' EXONUCLEASE ACTIVITY BY 5'-MONOPHOSPHATES OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND 3'-AMINO-3'-DEOXYTHYMIDINE [J].
BRIDGES, EG ;
FARAJ, A ;
SOMMADOSSI, JP .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (08) :1571-1576
[7]   Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine [J].
Collier, AC ;
Coombs, RW ;
Schoenfeld, DA ;
Bassett, RL ;
Timpone, J ;
Baruch, A ;
Jones, M ;
Facey, K ;
Whitacre, C ;
McAuliffe, VJ ;
Friedman, HM ;
Merigan, TC ;
Reichman, RC ;
Hooper, C ;
Corey, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (16) :1011-1017
[8]   CLINICAL PHARMACOKINETICS OF ZIDOVUDINE - AN OVERVIEW OF CURRENT DATA [J].
COLLINS, JM ;
UNADKAT, JD .
CLINICAL PHARMACOKINETICS, 1989, 17 (01) :1-9
[9]  
CZERNECKI S, 1991, SYNTHESIS-STUTTGART, P239
[10]   1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity [J].
Daluge, SM ;
Good, SS ;
Faletto, MB ;
Miller, WH ;
StClair, MH ;
Boone, LR ;
Tisdale, M ;
Parry, NR ;
Reardon, JE ;
Dornsife, RE ;
Averett, DR ;
Krenitsky, TA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1082-1093